Authors
Latest:
Advice for Sickle Cell Disease ManagementSophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger; and John J. Strouse, MD, PhD, share key takeaways and closing thoughts for the management of sickle cell disease.
Latest:
A Patient-Centric Medcast on The Journey Through Moderate Plaque PsoriasisAdvanced practice providers in dermatology discuss exciting developments in the treatment landscape of plaque psoriasis. Listen to their insights into the often-challenging journey patients go on. The arrival of novel oral systemic treatment options offers opportunities to alleviate the burden of this chronic disease.
Latest:
Advances in Treatment of Agitation Associated with Dementia Due to Alzheimer’s DiseaseExpert geriatric psychiatrists explore a frequently encountered symptom in Alzheimer’s disease, agitation. We will discuss its impact on patient’s and care giver’s quality of life, the current standard of care and the first FDA approved agent for treatment of agitation symptoms in Alzheimer’s disease.
Latest:
Treatment Decisions and its Relation to Patient AccessibilityFinal thoughts from expert KOLs regarding treatment decisions and how they relate to patient accessibility when manage dyslipidemia.
Latest:
Patient Education of HCMExpert cardiologists share strategies for educating patients on the treatment and management of hypertrophic cardiomyopathy.
Latest:
Management of Atopic Dermatitis in Pediatric and Adult PatientsIn this MEDcast episode,Raj Chovatiya, MD, PhD, and George Han, MD, PhD interview Vivian Shi, MD, FAAD, to discuss the latest clinical evidence on the management of atopic dermatitis (AD) in different age groups and patient factors to consider when selecting a treatment for AD.
Latest:
Screening for Alzheimer’s Disease: Facilitating an Early Diagnosis for Prompt InterventionIn this episode of MEDcast, expert geriatric psychiatrists explore the urgent need for effective diagnostic methods that can detect Alzheimer’s disease at an early stage. We will discuss blood-based biomarkers and other advancements that can help screen Alzheimer’s disease non-invasively and early in the disease course.
Latest:
Insulin Therapy and the Future of Type 2 Diabetes CareExpert clinicians discuss insulin therapy for treating type 2 diabetes and comment on what to look forward to in the future of diabetes care.
Latest:
Emerging Agents in The Treatment of GoutIn this discussion, experts focus on emerging treatment options for gout and share tips for monitoring and managing gout in patients with comorbid conditions.
Latest:
An Assessment of an EHR-Assisted Tobacco Treatment Model for GI Patients: Takeaways from ELEVATEHow an outpatient-based smoking cessation model may come to aid other health systems' gastroenterology patients.
Latest:
Pediatric Plaque PsoriasisThis publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.
Latest:
The Future of Plaque Psoriasis TreatmentBrad Glick, DO, MPH; Mona Shahriari, MD, FAAD; Michael Cameron, MD, FAAD; and Linda Stein Gold, MD, comment on the future of plaque psoriasis treatment and share clinical pearls on the management of plaque psoriasis.
Latest:
Key Takeaways on FMTs in the Treatment of CDIExperts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Latest:
Biomarkers for IgANPanelists discuss potential biomarkers and clinical indicators that can aid in predicting disease outcomes for individual patients with IgA nephropathy.
Latest:
Managing Insomnia: Practical Advice for Community PhysiciansClosing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Latest:
The Future of oHCM TreatmentAndrew Wang, MD; James Januzzi, MD; Michelle M. Kittleson, MD, PhD; and Milind Desai, MD, MBA, share a look into the future of oHCM treatment.
Latest:
Clinical trial data on IgAN for therapiesGerald B. Appel, MD, discusses the changing treatment landscape of IgAN.
Latest:
Clinical Pearls for the Treatment of ADExpert dermatologists share clinical pearls for providers treating patients with AD, and discuss the future of AD treatment.
Latest:
Strategies to Improve Screening and Diagnosis of T1DDrs Robert Busch, Robin S. Goland, Kimberly Simmons, and Teresa Quattrin discuss strategies to facilitate screening of type 1 diabetes and improve management of disease.
Latest:
Novel Research Frontiers on the Management of FCSPanelists discuss how various new and developing approaches for treating familial chylomicronemia syndrome are emerging, and emphasize the importance for clinicians to integrate these advancements into practice while staying current with ongoing research and evolving treatment strategies.
Latest:
Screening for Alzheimer’s Disease: Facilitating an Early Diagnosis for Prompt InterventionIn this episode of MEDcast, expert geriatric psychiatrists explore the urgent need for effective diagnostic methods that can detect Alzheimer’s disease at an early stage. We will discuss blood-based biomarkers and other advancements that can help screen Alzheimer’s disease non-invasively and early in the disease course.
Latest:
Milind Desai, MD: Real-World Safety Data Supports Mavacamten for oHCMMilind Desai, MD describes favorable real-world safety outcomes from mavacamten use over 22 months of the Risk Evaluation and Mitigation Strategy (REMS) program.
Latest:
Advice to Physicians Treating Geographic AtrophyDrs Eleonora M. Lad, David R. Lally, Jaynath R. Sridhar, and Nancy M. Holekamp share takeaways for health care professionals taking care of patients with geographic atrophy and earlier stages of age-related macular degeneration.
Latest:
Cardiometabolic Medicine: Seeing the Patient as a WholeThe panelists stress the significance of a comprehensive approach to patient care, acknowledging the interconnected nature of cardiovascular, kidney, endocrine, and obesity-related benefits, and highlighting that addressing secondary diseases can minimize overall disease risk in patients.
Latest:
Exploring the Cardiovascular Benefits, Potential of FinerenoneIn the final part of this 5-part series, Lala-Trindade discusses the findings of the FINEARTS-HF trial and how it might inform use of finerenone.
Latest:
Optimizing Care for ADHD During COVID-19Optimizing care and managing challenges for patients with ADHD during the COVID-19 pandemic and advice for clinicians educating patients and families on disease management.
